«2345678»Seite
10 Artikel mit Literatur, Seite 5 von 10

MEDIZIN: Übersichtsarbeit

Myokarditis: Frühzeitige Biopsie ermöglicht differenzierte regenerative Therapie

Myocarditis — early biopsy allows for tailored regenerative treatment
Dtsch Arztebl Int 2012; 109(20): 361-8; DOI: 10.3238/arztebl.2012.0361

Kühl, Uwe; Schultheiss, Heinz-Peter

1. Schultheiss HP, Kuehl U, Cooper LT: The management of myocarditis. Eur Heart J 2011; 32: 2616–65. CrossRef MEDLINE
2.D’Ambrosio A, Patti G, Manzoli A, et al.: The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001; 85: 499–504. CrossRef MEDLINE PubMed Central
3.Magnani JW, Dec GW: Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113: 876–90. CrossRef MEDLINE
4.Cooper LT, Baughman KL, Feldman AM, et al.: The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007; 28: 3076–93. CrossRef MEDLINE
5.Baboonian C, Treasure T: Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997; 78: 539–43. MEDLINE
6.Liu PP, Schultheiss HP: Myocarditis. In: Baunwald (ed.):, Heart Disease. 8 ed. Philadelphia: W B Saunders co; 2008: 1775–92.
7.McCarthy RE, Boehmer JP, Hruban RH, et al.: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690–5. CrossRef MEDLINE
8.Cooper LT Jr., Berry GJ, Shabetai R: Idiopathic giant-cell myocarditis- natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 1860–6. CrossRef MEDLINE
9.Why HJ, Meany BT, Richardson PJ, et al.: Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994; 89: 2582–9. MEDLINE
10.Mason JW, O’Connell JB, Herskowitz A, et al.: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269–75. CrossRef MEDLINE
11.Magnani JW, Suk Danik HJ, Dec GW, DiSalvo TG: Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathological, clinical, and hemodynamic predictors. Am Heart J 2006; 151: 463–70. CrossRef MEDLINE
12.Frustaci A, Chimenti C, Calabrese F, et al.: Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857–63. CrossRef MEDLINE
13.Caforio AL, Calabrese F, Angelini A, et al.: A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007; 28: 1326–33. CrossRef MEDLINE
14.Yilmaz A, Kindermann I, Kindermann M, et al.: Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 2010; 122: 900–9. CrossRef MEDLINE
15.Kuhl U, Lassner D, Pauschinger M, et al.: Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol 2008; 80: 1243–51. CrossRef MEDLINE
16.Kindermann I, Kindermann M, Kandolf R, et al.: Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118: 639–48. CrossRef MEDLINE
17.Hunt SA, Abraham WT, Chin MH, et al.: 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: e391–e479. CrossRef MEDLINE
18.Kühl U, Strauer BE, Schultheiss HP: Methylprednisolone in chronic myocarditis. Postgrad Med J 1994; 70: 35–42.
19.Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al.: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104: 39–45. MEDLINE
20.Stanton C, Mookadam F, Cha S, et al.: Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol 2008; 128: 38–41. CrossRef MEDLINE
21.Cooper L, Hare JM, Tazelaar HD, et al.: Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 2008; 102: 1535–9. CrossRef MEDLINE PubMed Central
22.Frustaci A, Russo MA, Chimenti C: Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009. CrossRef MEDLINE
23.Kuhl U, Pauschinger M, Seeberg B, et al.: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112: 1965–70. CrossRef
24.Kuhl U, Pauschinger M, Schwimmbeck PL, et al.: Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003; 107: 2793–8. CrossRef MEDLINE
25.Schultheiss HP, Piper C, Sowade K, et al.: The effect of subcutaneous treatment with interferon-beta-1b over 24 weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy. Circulation 2008: Abstract 3322.
e1.Aoyama N, Izumi T, Hiramori K, et al.: National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 2002; 66: 133–44. MEDLINE
e2.Mason JW: Techniques for right and left ventrikulär endomyocardial biopsy. Am J Cardiol 1978; 41: 887–94. MEDLINE
e3.Brehm M, Rellecke P, Strauer BE: Inflammatory cardiac diseases by primary extracardial diseases. Internist 2008; 49: 27–33. MEDLINE
e4.Aretz HT: Myocarditis: the Dallas criteria. Hum Pathol 1987; 18: 619–24. CrossRef MEDLINE
e5.Kuhl U, Noutsias M, Seeberg B, Schultheiss HP: Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996; 75: 295–300. CrossRef MEDLINE PubMed Central
e6.Noutsias M, Pauschinger M, Ostermann K, et al.: Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 2002; 8: MT59–71. MEDLINE
e7.Okura Y, Dec GW, Hare JM, et al: A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 2003; 41: 322–9. MEDLINE
«2345678»Seite
10 Artikel mit Literatur, Seite 5 von 10

Login

E-Mail

Passwort


Passwort vergessen?

Registrieren

Eingeloggt als

Suchen in